EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Proposed Risk of Bias Assessment Tool for In Vitro Antimicrobial Susceptibility Studies

Matthew E Falagas, Dimitrios Ragias iD, Dimitrios S Kontogiannis, Laura T Romanos, Paraskevi A Farazi iD

Pathogens · 2026-04-07 · 15 (4) · 396

DOI: 10.3390/pathogens15040396 ↗

At a glance

Journal article in Pathogens, published online on 2026-04-07. Written by Matthew E Falagas and 4 co-authors. Institution: Alfa Institute of Biomedical Sciences (AIBS), Marousi, 151 23 Athens, Greece. Major MEDLINE topics: Anti-Infective Agents, Bias, Microbial Sensitivity Tests. Cited 5 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The assessment of risk of bias in systematic reviews and meta-analyses is crucial, as it indicates the accuracy of the synthesized and evaluated data and the validity of the presented results and conclusions. Until now, standardized tools for this purpose have been available only for clinical and animal studies, while adapted forms of these tools and novel ones have been proposed for in vitro and laboratory studies. However, none of them have been universally standardized so far. The apparent lack of a risk of bias assessment tool for systematic reviews of in vitro antimicrobial susceptibility testing studies constitutes a methodological flaw in these studies. To this end, we developed a risk of bias assessment tool for in vitro antimicrobial susceptibility testing studies. Our tool assesses the risk of bias across six domains: methodological bias, selection bias, preparation bias (including contamination/cross-contamination bias), measurement/observer bias, reporting and publication bias, and bias related to unreported funding and conflicts of interest. The tool evaluates a total of 16 specific criteria. The risk of bias is graded as low, moderate, or high for each evaluated criterion. The proposed risk of bias assessment tool was tested in a pilot validation study of ten relevant studies by two reviewers independently. We believe that the use of the proposed risk of bias assessment tool will increase the methodological strength of systematic reviews and meta-analyses of in vitro antimicrobial susceptibility testing studies.

Subjects

MeSH terms (MEDLINE)

Anti-Infective AgentsBiasMicrobial Sensitivity TestsAnimalsHumansMeta-Analysis as TopicResearch DesignRisk AssessmentSystematic Reviews as Topic

Author keywords

contamination/cross-contamination biasheterogeneitymeasurement/observer biasmethodological biaspublication biasreporting biasrisk of biasselection bias

Substances

Anti-Infective Agents

Authors and institutions

  • Alfa Institute of Biomedical Sciences (AIBS), Marousi, 151 23 Athens, Greece.
  • School of Medicine, European University Cyprus, 2404 Nicosia, Cyprus.
  • Department of Medicine, Tufts University School of Medicine, Boston, MA 02111, USA.

ORCID profiles: Dimitrios Ragias, Paraskevi A Farazi

Cite

APA

Falagas, M. E., Ragias, D., Kontogiannis, D. S., Romanos, L. T., & Farazi, P. A. (2026). Proposed Risk of Bias Assessment Tool for In Vitro Antimicrobial Susceptibility Studies. Pathogens, 15(4), 396. https://doi.org/10.3390/pathogens15040396

Vancouver

Falagas ME, Ragias D, Kontogiannis DS, Romanos LT, Farazi PA. Proposed Risk of Bias Assessment Tool for In Vitro Antimicrobial Susceptibility Studies. Pathogens. 2026;15(4):396. doi:10.3390/pathogens15040396

BibTeX
@article{Falagas2026,
  author = {Falagas, Matthew E and Ragias, Dimitrios and Kontogiannis, Dimitrios S and Romanos, Laura T and Farazi, Paraskevi A},
  title = {Proposed Risk of Bias Assessment Tool for In Vitro Antimicrobial Susceptibility Studies},
  journal = {Pathogens},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {396},
  doi = {10.3390/pathogens15040396}
}
Start for free →